09/07/2026
On World Duchenne Awareness Day, September 7, we unite around the theme “Access Changes Lives.”
Andrew the “Ande-” in Andelyn, received the first U.S. investigational gene therapy for Duchenne muscular dystrophy in 2006. That access helped shape his journey as a gene therapy pioneer and continues to inspire the work of the Andelyn Foundation.
The Andelyn Foundation reflects a commitment to expanding access and supporting the Duchenne community, because every family deserves timely diagnosis, specialist care, innovative treatments, trustworthy information, and inclusive opportunities.
Access changes lives.